Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.76B | 21.1x | -0.27 | MYR 2.43 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Duopharma Biotech | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.21B | 21.5x | -2.36 | MYR 1.25 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | |
Amway | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.12B | 9.1x | 0.61 | MYR 6.80 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.6% Upside | Upgrade to Pro+ | |
Kotra Industries | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 654.07M | 16.1x | -0.51 | MYR 4.41 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.7% Upside | Upgrade to Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 518.84M | 5.5x | 0.05 | MYR 0.35 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
YSP Southeast Asia | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 326.24M | 11.4x | -0.64 | MYR 2.30 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhone Ma | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 148.22M | 12.1x | 1.89 | MYR 0.67 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.7% Upside | Upgrade to Pro+ | |
Bioalpha | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 91.42M | -2.1x | -0.12 | MYR 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |